Answer
Xadago (safinamide) is used in adults with idiopathic Parkinson’s disease who have mid- to late-stage motor fluctuations, as add-on therapy to a stable dose of levodopa, alone or combined with other Parkinson’s medicines.
Sources for this answer
- Xadago 50mg film-coated tabletsZambon UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked